Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Safety and efficacy of clopidogrel treatment in Japanese patients undergoing drug-eluting stent implantation.

Hayashi F, Iijima R, Nakamura M, Sugi K.

J Cardiol. 2010 Jan;55(1):34-40. doi: 10.1016/j.jjcc.2009.08.002. Epub 2009 Sep 19.

2.

Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.

Calver AL, Blows LJ, Harmer S, Dawkins KD, Gray HH, Morgan JH, Simpson IA.

Am Heart J. 2000 Sep;140(3):483-91.

PMID:
10966552
3.

A high maintenance dose of clopidogrel improves short-term clinical outcomes in patients with acute coronary syndrome undergoing drug-eluting stent implantation.

Han YL, Wang B, Li Y, Xu K, Wang SL, Jing QM, Wang ZL, Wang DM, Ma YY, Wang G.

Chin Med J (Engl). 2009 Apr 5;122(7):793-7.

PMID:
19493391
4.

Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement.

Sibbing D, Schulz S, Braun S, Morath T, Stegherr J, Mehilli J, Schömig A, von Beckerath N, Kastrati A.

J Thromb Haemost. 2010 Feb;8(2):250-6. doi: 10.1111/j.1538-7836.2009.03709.x. Epub 2009 Nov 28.

5.

Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation.

Roy P, Bonello L, Torguson R, de Labriolle A, Lemesle G, Slottow TL, Steinberg DH, Kaneshige K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R.

Am J Cardiol. 2008 Dec 15;102(12):1614-7. doi: 10.1016/j.amjcard.2008.07.063. Epub 2008 Sep 27.

PMID:
19064014
7.

Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation.

Sarafoff N, Ndrepepa G, Mehilli J, Dörrler K, Schulz S, Iijima R, Byrne R, Schömig A, Kastrati A.

J Intern Med. 2008 Nov;264(5):472-80. doi: 10.1111/j.1365-2796.2008.01989.x. Epub 2008 Jun 25.

8.

Clopidogrel use and clinical events after drug-eluting stent implantation: findings from the HealthCore Integrated Research Database.

Petersen JL, Barron JJ, Hammill BG, Cziraky MJ, Anstrom KJ, Wahl PM, Eisenstein EL, Krucoff MW, Califf RM, Schulman KA, Curtis LH.

Am Heart J. 2010 Mar;159(3):462-470.e1. doi: 10.1016/j.ahj.2009.11.031.

PMID:
20211310
9.

Clopidogrel as adjunctive antiplatelet therapy during coronary stenting.

Mishkel GJ, Aguirre FV, Ligon RW, Rocha-Singh KJ, Lucore CL.

J Am Coll Cardiol. 1999 Dec;34(7):1884-90.

10.
11.
12.

Delays in filling clopidogrel prescription after hospital discharge and adverse outcomes after drug-eluting stent implantation: implications for transitions of care.

Ho PM, Tsai TT, Maddox TM, Powers JD, Carroll NM, Jackevicius C, Go AS, Margolis KL, DeFor TA, Rumsfeld JS, Magid DJ.

Circ Cardiovasc Qual Outcomes. 2010 May;3(3):261-6. doi: 10.1161/CIRCOUTCOMES.109.902031. Epub 2010 Apr 20.

13.

Clopidogrel trial in patients with elective percutaneous coronary intervention for stable angina and old myocardial infarction (CLEAN).

Isshiki T, Kimura T, Ueno T, Nakamura M, Igarashi K, Yokoi H, Kobayashi M, Ikari Y.

Int Heart J. 2012;53(2):91-101.

14.

Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation.

Moussa I, Oetgen M, Roubin G, Colombo A, Wang X, Iyer S, Maida R, Collins M, Kreps E, Moses JW.

Circulation. 1999 May 11;99(18):2364-6.

15.

Safety and efficacy evaluation of clopidogrel compared to ticlopidine after stent implantation: an updated meta-analysis.

Casella G, Ottani F, Pavesi PC, Sangiorgio P, Rubboli A, Galvani M, Fontanelli A, Bracchetti D.

Ital Heart J. 2003 Oct;4(10):677-84.

PMID:
14664280
16.

Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.

Wang ZJ, Zhou YJ, Liu YY, Yu M, Shi DM, Zhao YX, Guo YH, Cheng WJ, Jia de A, Cao Z, Nie B, Ge HL, Yang SW, Yan ZX.

Thromb Res. 2009 May;124(1):46-51. doi: 10.1016/j.thromres.2008.10.007. Epub 2008 Nov 28.

PMID:
19041120
17.

Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.

Rossini R, Musumeci G, Lettieri C, Molfese M, Mihalcsik L, Mantovani P, Sirbu V, Bass TA, Della Rovere F, Gavazzi A, Angiolillo DJ.

Am J Cardiol. 2008 Dec 15;102(12):1618-23. doi: 10.1016/j.amjcard.2008.08.021. Epub 2008 Sep 24.

PMID:
19064015
18.

Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.

Orford JL, Fasseas P, Melby S, Burger K, Steinhubl SR, Holmes DR, Berger PB.

Am Heart J. 2004 Mar;147(3):463-7.

PMID:
14999195
19.

Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions.

Brar SS, Kim J, Brar SK, Zadegan R, Ree M, Liu IL, Mansukhani P, Aharonian V, Hyett R, Shen AY.

J Am Coll Cardiol. 2008 Jun 10;51(23):2220-7. doi: 10.1016/j.jacc.2008.01.063.

20.

The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.

Best PJ, Steinhubl SR, Berger PB, Dasgupta A, Brennan DM, Szczech LA, Califf RM, Topol EJ; CREDO Investigators.

Am Heart J. 2008 Apr;155(4):687-93. doi: 10.1016/j.ahj.2007.10.046. Epub 2008 Feb 21.

PMID:
18371477

Supplemental Content

Support Center